ARCHIVES

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Patent For Semisynthetic Taxol Issued To FL Scientist; Simone To Chair Pediatric Group

June 7, 1991

Experts Concerned As Phase I Studies Reach Deeper Into Community Practice (Second story in a two-part series.)

April 2, 2010

NCI Advisory Group, Other Cancer Meetings

October 26, 1984

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

DCT Board Okay Recompetitions, Delays Decision On Clonogenic Assays

June 24, 1983

FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine

June 16, 1989